Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin(Uppsala University), Robert A. Harrington(Clinical Research Institute), Andrzej Budaj, Jay Horrow(Wilmington University), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Robert F. Storey(University of Sheffield), Steen Husted(University of Copenhagen), Benjamin M. Scirica(Brigham and Women's Hospital), Hugo A. Katus(Heidelberg University), Stefan James(Uppsala University), Claes Held(Uppsala University), Christopher P. Cannon(Brigham and Women's Hospital), Allan M. Skene, Philippe Gabríel Steg(Mount Sinai Hospital), Håkan Emanuelsson(AstraZeneca (Sweden)), Richard C. Becker(University of Cincinnati)
Cited by 7,065
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k